Medical Condition News

RSS

Researchers find novel drug target for anaplastic thyroid carcinomas

Anaplastic thyroid carcinomas are aggressive tumors that do not respond to traditional radio- or chemotherapeutic agents, and there currently is no cure or effective treatment available. Median survival from diagnosis is 5 months, and although ATC accounts for only 1.7% of all thyroid cancers in the U.S., it is responsible for a large proportion of thyroid cancer-related deaths.

17 Oct 2013

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Working with mice genetically engineered to display symptoms of schizophrenia, neuroscientists at the RIKEN-MIT Center for Neural Circuit Genetics at the Picower Institute for Learning and Memory at MIT have uncovered a faulty brain mechanism that may underlie schizophrenia and other psychiatric disorders in humans.

17 Oct 2013

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Examining 12 major types of cancer, scientists at Washington University School of Medicine in St. Louis have identified 127 repeatedly mutated genes that appear to drive the development and progression of a range of tumors in the body. The discovery sets the stage for devising new diagnostic tools and more personalized cancer treatments.

17 Oct 2013

Researchers discover why women with BRCA gene develop breast and ovarian cancer

Researchers announced today in the journal Lancet Oncology that they are well on the way to discovering why women with the faulty genes BRCA 1 and BRCA 2, one of which was inherited by the actress Angelina Jolie, develop breast and ovarian cancer rather than other cancers.

17 Oct 2013

Babies born to teen mothers have underdeveloped speaking skills, says study

Babies born to teen mothers have less developed speaking skills at age five than children of older mothers, a new study has found.

17 Oct 2013

Researchers develop new tool to quantify myocardial damage in heart attack patients

Researchers from the Computer Vision Center (CVC) have developed a new tool to quantify the myocardial perfusion damage in people who had a heart attack or an angina. Having been validated in 200 patients, it can help improve and speed up diagnosis of the damage, offering a quantitative, repeatable and objective measure of the blood irrigation level of the heart tissue.

17 Oct 2013

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation , today announced the results of the MPACT phase III clinical trial of ABRAXANE® in combination with gemcitabine were published online in the October 16th edition of the New England Journal of Medicine.

17 Oct 2013

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

For the first time, a simple blood test may be the best way to determine if a patient is suffering from Irritable Bowel Syndrome, or another serious condition such as Inflammatory Bowel Disease, according to Cedars-Sinai physician researcher Mark Pimentel, MD, lead author of a multicenter clinical trial.

17 Oct 2013

Study shows treatment for hypothyroidism is not associated with weight loss in most people

Decreased thyroid function, or hypothyroidism, is commonly associated with weight gain. But contrary to popular belief, effective treatment with levothyroxine (LT4) to restore normal thyroid hormone levels is not associated with clinically significant weight loss in most people.

17 Oct 2013

Simple urine test uses nanotechnology to detect dangerous blood clotting

Life-threatening blood clots can form in anyone who sits on a plane for a long time, is confined to bed while recovering from surgery, or takes certain medications.

17 Oct 2013

Discovery of neural firing-rate set point opens door to possible treatment for devastating disorders

As we learn and develop, our neurons change. They make new pathways and connections as our brain processes new information. In order to do this, individual neurons use an internal gauge to maintain a delicate balance that keeps our brains from becoming too excitable.

17 Oct 2013

Light pulses stimulate designer peptides to trigger death pathway in cancerous cells

Researchers at Cardiff University have created a peptide (a small piece of protein), linked to a light-responsive dye, capable of switching 'on' death pathways in cancer cells. The peptide remains inactive until exposed to external light pulses which convert it into a cell death signal.

17 Oct 2013

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

A Johns Hopkins-led analysis of data previously gathered on more than 3,000 elderly Americans strongly suggests that taking certain blood pressure medications to control blood pressure may reduce the risk of dementia due to Alzheimer's disease.

17 Oct 2013

Respicardia awarded U.S. Healthcare Product of the Year for remede System

Respicardia®, Inc., a developer of implantable therapies to improve respiratory and cardiovascular health, announced that it has been awarded the U.S. Healthcare Product of the Year by Acquisition International for the remede System, the first and only implantable device for the treatment of central sleep apnea.

16 Oct 2013

New app for intelligent glasses could improve gait of Parkinson's disease patients

A new app for intelligent glasses, such as Google Glass, will soon make it possible to improve the gait of patients suffering from Parkinson's disease and to decrease their risk of falling. Researchers at the University of Twente's MIRA Institute have received a grant from the NutsOhra fund for the development of the app.

16 Oct 2013

Proper sleep helps maintain a healthy lifestyle

Three new studies show just how critical it is for adults to seek treatment for a sleep illness and aim for seven to nine hours of sleep each night in order to maintain a healthy lifestyle.

16 Oct 2013

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

The impact of bariatric surgery on risk factors for cardiovascular disease depends on a variety of factors, including the type of surgery, sex of the patient, ethnic background, and pre-surgery body mass index, according to a Kaiser Permanente study published today in Annals of Surgery.

16 Oct 2013

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

The Detroit Lions and Josephine Ford Cancer Institute, Michigan's largest provider of adult cancer care, have created a unique partnership with the goal to raise $15 million during the next three years for cancer research in metro Detroit.

16 Oct 2013

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it will collaborate with a pharmaceutical company to evaluate Trovagene's proprietary, urine-based, cell-free DNA technology for the detection of certain epidermal growth factor receptor mutations associated with lung cancer.

16 Oct 2013

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

ESTEVE, a pharmaceutical company focused on developing novel therapeutics for pain today announces positive top line results from its recently completed phase II trial, which was designed to evaluate the efficacy and safety of E-58425 in acute pain.

16 Oct 2013

Medical Condition News

Researchers find novel drug target for anaplastic thyroid carcinomas

Scientists uncover faulty brain mechanism that may underlie schizophrenia in humans

Scientists identify 127 mutated genes that appear to drive development of tumors in the body

Researchers discover why women with BRCA gene develop breast and ovarian cancer

Babies born to teen mothers have underdeveloped speaking skills, says study

Researchers develop new tool to quantify myocardial damage in heart attack patients

New England publishes results of phase III clinical trial of ABRAXANE for metastatic pancreatic cancer

Researchers develop simple blood test to identify patient with Irritable Bowel Syndrome

Study shows treatment for hypothyroidism is not associated with weight loss in most people

Simple urine test uses nanotechnology to detect dangerous blood clotting

Discovery of neural firing-rate set point opens door to possible treatment for devastating disorders

Light pulses stimulate designer peptides to trigger death pathway in cancerous cells

Certain blood pressure medications may reduce risk of dementia due to Alzheimer's disease

Respicardia awarded U.S. Healthcare Product of the Year for remede System

New app for intelligent glasses could improve gait of Parkinson's disease patients

Proper sleep helps maintain a healthy lifestyle

Non-Hispanic black, Hispanic patients less likely to experience metabolic syndrome remission

Detroit Lions, Josephine Ford Cancer Institute to raise $15M for cancer research in metro Detroit

Trovagene launches pharmaceutical alliance to monitor lung cancer patients' EGFR mutational status

ESTEVE reports positive top line results from E-58425 phase II trial for acute pain

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News